This is a working overview of lyophilization, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-21. Anything still debated is marked as such rather than presented as settled.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Free peptide form |
| Molecular mass | About 751.9 Da | Calculated average mass |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Single-letter form TKPRPGP |
| Structural basis | Tuftsin analogue | Extended version of a natural tetrapeptide |
| Development origin | Russian Academy of Sciences | Work carried out from the 1980s onward |
Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
== Literatur == Peter Burschel, Jürgen Huss: Grundriß des Waldbaus. Ein Leitfaden für Studium und Praxis. 2., neubearbeitete und erweiterte Auflage. Parey, Berlin 1997, ISBN 3-8263-3045-5. Fritz Schwerdtfeger: Die Waldkrankheiten. Lehrbuch der Forstpathologie und des Forstschutzes. 4., neubearbeitete Auflage. Parey, Hamburg / Berlin 1981, ISBN 3-490-09116-7. Mart-Jan Schelhaas: Impacts of natural disturbances on the development of European forest resources. Application of model approaches from tree and stand levels to large-scale scenarios. (Alterra Scientific contributions 23). Alterra, Wageningen 2008, ISBN 978-90-327-0356-1. Rudi Holzberger: Das sogenannte Waldsterben : zur Karriere eines Klischees: das Thema Wald im journalistischen Diskurs. Eppe, Bergatreute 2002, ISBN 3-89089-750-9.
Literatur von und über Waldschäden im Katalog der Deutschen Nationalbibliothek Datenbank für Waldschäden in Europa (DFDE), European Forest Institute, Joensuu, Finnland. Online verfügbar unter https://efi.int/publications-bank/database-forest-disturbances-europe-dfde-technical-description
Die Katholische Deutsche Studentenverbindung Nassovia (KDStV Nassovia) zu Darmstadt im CV ist eine farbentragende, nichtschlagende Studentenverbindung, die dem größten interdisziplinären Akademikerverband Deutschlands, dem Cartellverband der katholischen deutschen Studentenverbindungen (CV) angehört. Nassovia war ein Mitgründer des Starkenburger Cartellverbandes.
== Geschichte == Die KDStV Nassovia wurde am 28. Oktober 1896 an der Technischen Hochschule Darmstadt gegründet. Abgesehen von dem nicht farbentragenden Akademischen Verein Darmstadt, der sich selbst 1889 zur studentischen Korporation erklärt hatte, war Nassovia die erste nichtschlagende Verbindung in Darmstadt. Zudem war sie die erste konfessionelle Verbindung in Darmstadt. Gegen die Gründung konfessioneller Verbindungen demonstrierten 1896 tausende Studenten in Darmstadt und auch an anderen technischen Hochschulen im Rahmen des akademischen Kulturkampfes. Den katholischen Studentenverbindungen wurde von einer Versammlung von 700 Darmstädter Studenten die Existenzberechtigung abgesprochen und die Forderung erhoben, diese und insbesondere die Nassovia von allen Festlichkeiten auszuschließen; Rektor und Senat stellten sich jedoch auf die Seite der Nassovia und forderten die Studentenschaft auf, die Ablehnung der Nassovia aufzugeben, da dies gegen die Statuten der Hochschule verstoße und einen Eingriff in die akademische Freiheit darstelle. Gründungssenior der Nassovia war Joseph Kehrein (1872–1948). Sie wurde zunächst im Jahre 1897 als befreundete Verbindung in den Cartellverband der katholischen deutschen Studentenverbindungen aufgenommen. Mit den anderen CV-Anwärtern KDStV Normannia Karlsruhe und KDStV Rheno-Saxonia aus Köthen (heute Halle) gründete sie den Starkenburger Cartellverband (in Anlehnung an die hessische Provinz Starkenburg).
Sources: de.wikipedia.org
It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.
The core four residues correspond to tuftsin, which occurs naturally as part of immunoglobulin G. The full seven-residue sequence, however, is not a known endogenous peptide. It is a laboratory-designed analogue intended to combine tuftsin-like activity with greater resistance to breakdown.
No single receptor has been confirmed as the primary target. Reports describe involvement of the GABAergic system, interference with enkephalin degradation, and shifts in neurotrophic factor expression. Because these observations come from different models and assays, they have not yet been integrated into one accepted mechanism.
Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.